🟢 Lantern Pharma is trading 12.35% up today with no confirmed catalyst

Lantern Pharma is trading 12.35% up at $1.91 on September 16, 2026, despite broader biotech weakness; the move remains unexplained.

• No company-specific announcement dated September 16 was identified.
• The latest notable company updates were earlier in 2026.
• No confirmed earnings, FDA, deal, analyst, or guidance catalyst was identified, while XBI is declining.